Charles Divita III sold $257k of TDOC
CHIEF EXECUTIVE OFFICER at Teladoc Health, Inc.. 50,145 shares at an average of $5.12, traded Mar 2, 2026, filed Mar 3, 2026.
Score components
- +25RoleCEO
- +13Trade size$257k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +3.3%, 3m +47.8%, 6m +22.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001347535-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 27, 2022 | MOption exercise Common Stock | +169,107 | - | - | 370,143 | Mar 3, 2026 |
| Feb 27, 2026 | MOption exercise Common Stock | +7,864 | - | - | 378,007 | Mar 3, 2026 |
| Mar 2, 2026 | SOpen-market sale Common Stock | -50,145 | $5.12 | $257k | 327,862 | Mar 3, 2026 |
| Feb 27, 2026 | MOption exercise Restricted Stock Unitsderivative | -169,107 | $0.00 | $0 | 338,215 | Mar 3, 2026 |
| Feb 27, 2026 | AGrant or award Performance Stock Unitsderivative | +23,591 | $0.00 | $0 | 23,591 | Mar 3, 2026 |
| Feb 27, 2026 | MOption exercise Performance Stock Unitsderivative | -7,864 | $0.00 | $0 | 15,727 | Mar 3, 2026 |
| Mar 1, 2026 | AGrant or award Restricted Stock Unitsderivative | +692,041 | $0.00 | $0 | 692,041 | Mar 3, 2026 |
Related signals
Other insiders at Teladoc Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | TDOCsell Teladoc Health, Inc. | Joseph Ronald Catapano Chief Accounting Officer | $3,703 655 shares | -4% | |
| 35Weak | Teladoc Health, Inc. | Charles Divita III CHIEF EXECUTIVE OFFICER | $109k 17,805 shares | -4% | |
| 26Weak | Teladoc Health, Inc. | Kelly Bliss President, U.S. Group Health | $46k 7,357 shares | -7% | |
| 15Weak | Teladoc Health, Inc. | Joseph Ronald Catapano Chief Accounting Officer | $1,726 274 shares | -2% | |
| 35Weak | Teladoc Health, Inc. | Charles Divita III CHIEF EXECUTIVE OFFICER | $115k 18,327 shares | -4% | |
| 26Weak | Teladoc Health, Inc. | Carlos Nueno President, International | $39k 6,200 shares | -9% | |
| 30Weak | Teladoc Health, Inc. | Fernando M. Rodrigues President of BetterHelp | $98k 15,251 shares | -100% | |
| 22Weak | Teladoc Health, Inc. | Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY | $48k 7,573 shares | -6% | |
| 8Weak | Teladoc Health, Inc. | Kelly Bliss President, U.S. Group Health | $24k 2,500 shares | -3% | |
| 8Weak | Teladoc Health, Inc. | Joseph Ronald Catapano Chief Accounting Officer | $5,942 653 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.